IN2013DN02555A - - Google Patents
Download PDFInfo
- Publication number
- IN2013DN02555A IN2013DN02555A IN2555DEN2013A IN2013DN02555A IN 2013DN02555 A IN2013DN02555 A IN 2013DN02555A IN 2555DEN2013 A IN2555DEN2013 A IN 2555DEN2013A IN 2013DN02555 A IN2013DN02555 A IN 2013DN02555A
- Authority
- IN
- India
- Prior art keywords
- compounds
- processes
- relates
- disorders
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38573310P | 2010-09-23 | 2010-09-23 | |
| US201161533349P | 2011-09-12 | 2011-09-12 | |
| PCT/US2011/052254 WO2012040139A1 (en) | 2010-09-23 | 2011-09-20 | Oxadiazole inhibitors of leukotriene production |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2013DN02555A true IN2013DN02555A (pt) | 2015-08-07 |
Family
ID=44720163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2555DEN2013 IN2013DN02555A (pt) | 2010-09-23 | 2011-09-20 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8575201B2 (pt) |
| EP (1) | EP2619197B1 (pt) |
| JP (1) | JP5713511B2 (pt) |
| KR (1) | KR20130109122A (pt) |
| CN (1) | CN103261193A (pt) |
| AU (1) | AU2011305667A1 (pt) |
| BR (1) | BR112013008638A2 (pt) |
| CA (1) | CA2812449A1 (pt) |
| CL (1) | CL2013000788A1 (pt) |
| CO (1) | CO6710902A2 (pt) |
| EA (1) | EA201300389A1 (pt) |
| EC (1) | ECSP13012548A (pt) |
| IN (1) | IN2013DN02555A (pt) |
| MX (1) | MX2013003202A (pt) |
| PE (1) | PE20131398A1 (pt) |
| SG (1) | SG188604A1 (pt) |
| WO (1) | WO2012040139A1 (pt) |
| ZA (1) | ZA201301747B (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5862669B2 (ja) * | 2010-08-26 | 2016-02-16 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ロイコトリエン産生のオキサジアゾール阻害剤 |
| US8580825B2 (en) * | 2010-09-23 | 2013-11-12 | Boehringer Ingelheim International Gmbh | Oxadiazole inhibitors of leukotriene production |
| CN103261193A (zh) | 2010-09-23 | 2013-08-21 | 贝林格尔.英格海姆国际有限公司 | 抑制白三烯生成的*二唑抑制剂 |
| AR089853A1 (es) | 2012-02-01 | 2014-09-24 | Boehringer Ingelheim Int | Inhibidores de oxadiazol de la produccion de leucotrienos para terapia de combinacion, composicion farmaceutica, uso |
| US9079866B2 (en) * | 2013-02-04 | 2015-07-14 | Janssen Pharmaceutica Nv | Flap modulators |
| EP2875736B1 (en) | 2013-11-26 | 2016-07-27 | Citrage | N-Carbamoylputrescine to enhance muscle protein synthesis |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ516506A (en) | 1999-08-06 | 2004-02-27 | Janssen Pharmaceutica Nv | Interleukin-5 inhibiting 6-azauracil derivatives |
| EP1653970A4 (en) * | 2003-08-13 | 2008-10-15 | Novartis Vaccines & Diagnostic | GSK-3 INHIBITORS AND USES |
| US7319108B2 (en) | 2004-01-25 | 2008-01-15 | Sanofi-Aventis Deutschland Gmbh | Aryl-substituted heterocycles, process for their preparation and their use as medicaments |
| US20070287736A1 (en) | 2004-10-18 | 2007-12-13 | Lin Chu | Diphenyl Substituted Alkanes as Flap Inhibitors |
| US8399666B2 (en) * | 2005-11-04 | 2013-03-19 | Panmira Pharmaceuticals, Llc | 5-lipoxygenase-activating protein (FLAP) inhibitors |
| US7977359B2 (en) * | 2005-11-04 | 2011-07-12 | Amira Pharmaceuticals, Inc. | 5-lipdxygenase-activating protein (FLAP) inhibitors |
| GB2431927B (en) | 2005-11-04 | 2010-03-17 | Amira Pharmaceuticals Inc | 5-Lipoxygenase-activating protein (FLAP) inhibitors |
| CA2648555A1 (en) * | 2006-04-11 | 2007-10-25 | Merck & Co., Inc. | Diaryl substituted alkanes |
| CA2787343C (en) | 2006-06-26 | 2016-08-02 | Amgen Inc. | Compositions comprising modified lcat and uses thereof |
| JP2010502615A (ja) * | 2006-09-01 | 2010-01-28 | メルク エンド カムパニー インコーポレーテッド | ５−リポキシゲナーゼ活性化タンパク質（ｆｌａｐ）の阻害剤 |
| WO2008128335A1 (en) | 2007-04-20 | 2008-10-30 | Merck Frosst Canada Ltd. | Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| EP2170065A4 (en) | 2007-06-20 | 2011-11-23 | Merck Sharp & Dohme | DIPHENYL SUBSTITUTED ALKANES |
| US20110003815A1 (en) | 2007-10-10 | 2011-01-06 | Merck & Co., Inc. | Diphenyl substituted cycloalkanes |
| DE102008037790A1 (de) * | 2008-08-14 | 2010-02-18 | Merck Patent Gmbh | Bicyclische Triazolderivate |
| MX2011004570A (es) * | 2008-10-31 | 2011-06-17 | Merck Sharp & Dohme | Antagonistas del receptor p2x3 para el tratamiento del dolor. |
| JP2012516885A (ja) | 2009-02-04 | 2012-07-26 | ファイザー・インク | ４−アミノ−７，８−ジヒドロピリド［４，３−ｄ］ピリミジン−５（６Ｈ）−オン誘導体 |
| SG185414A1 (en) | 2010-05-12 | 2012-12-28 | Univ Vanderbilt | Heterocyclic sulfone mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| JP5619284B2 (ja) * | 2010-08-16 | 2014-11-05 | ベーリンガーインゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ロイコトリエン産生のオキサジアゾール阻害薬 |
| JP5862669B2 (ja) * | 2010-08-26 | 2016-02-16 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ロイコトリエン産生のオキサジアゾール阻害剤 |
| US8580825B2 (en) * | 2010-09-23 | 2013-11-12 | Boehringer Ingelheim International Gmbh | Oxadiazole inhibitors of leukotriene production |
| CN103261193A (zh) | 2010-09-23 | 2013-08-21 | 贝林格尔.英格海姆国际有限公司 | 抑制白三烯生成的*二唑抑制剂 |
-
2011
- 2011-09-20 CN CN2011800565586A patent/CN103261193A/zh active Pending
- 2011-09-20 SG SG2013020300A patent/SG188604A1/en unknown
- 2011-09-20 IN IN2555DEN2013 patent/IN2013DN02555A/en unknown
- 2011-09-20 BR BR112013008638A patent/BR112013008638A2/pt not_active IP Right Cessation
- 2011-09-20 AU AU2011305667A patent/AU2011305667A1/en not_active Abandoned
- 2011-09-20 CA CA2812449A patent/CA2812449A1/en not_active Abandoned
- 2011-09-20 EA EA201300389A patent/EA201300389A1/ru unknown
- 2011-09-20 PE PE2013000629A patent/PE20131398A1/es not_active Application Discontinuation
- 2011-09-20 EP EP11761775.3A patent/EP2619197B1/en active Active
- 2011-09-20 MX MX2013003202A patent/MX2013003202A/es active IP Right Grant
- 2011-09-20 US US13/237,112 patent/US8575201B2/en active Active
- 2011-09-20 WO PCT/US2011/052254 patent/WO2012040139A1/en active Application Filing
- 2011-09-20 JP JP2013530221A patent/JP5713511B2/ja active Active
- 2011-09-20 KR KR1020137007287A patent/KR20130109122A/ko not_active Application Discontinuation
-
2013
- 2013-03-07 ZA ZA2013/01747A patent/ZA201301747B/en unknown
- 2013-03-21 CL CL2013000788A patent/CL2013000788A1/es unknown
- 2013-03-22 CO CO13057875A patent/CO6710902A2/es not_active Application Discontinuation
- 2013-04-11 EC ECSP13012548 patent/ECSP13012548A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2011305667A1 (en) | 2013-03-21 |
| ECSP13012548A (es) | 2013-06-28 |
| MX2013003202A (es) | 2013-04-24 |
| WO2012040139A1 (en) | 2012-03-29 |
| KR20130109122A (ko) | 2013-10-07 |
| JP2013537909A (ja) | 2013-10-07 |
| US20120295896A1 (en) | 2012-11-22 |
| CL2013000788A1 (es) | 2013-06-28 |
| ZA201301747B (en) | 2014-08-27 |
| US8575201B2 (en) | 2013-11-05 |
| EA201300389A1 (ru) | 2013-09-30 |
| EP2619197B1 (en) | 2015-08-05 |
| EP2619197A1 (en) | 2013-07-31 |
| CO6710902A2 (es) | 2013-07-15 |
| CN103261193A (zh) | 2013-08-21 |
| CA2812449A1 (en) | 2012-03-29 |
| BR112013008638A2 (pt) | 2016-06-21 |
| SG188604A1 (en) | 2013-04-30 |
| PE20131398A1 (es) | 2013-12-19 |
| JP5713511B2 (ja) | 2015-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12014502524A1 (en) | Carboxylic acid compounds | |
| IN2014MN00988A (pt) | ||
| PH12015500457A1 (en) | Alkoxy pyrazoles as soluble guanylate cyclase activators | |
| MD20140063A2 (ro) | Derivaţi de acid benzotiazol-6-il acetic şi utilizarea acestora pentru tratarea unei infecţii HIV | |
| IN2015DN01119A (pt) | ||
| UA104489C2 (uk) | Сполуки для лікування дисліпідемії та споріднених хвороб | |
| IN2014DN09352A (pt) | ||
| AU2011286276A8 (en) | Substituted Biphenylene Compounds and methods of use thereof for the treatment of viral diseases | |
| IN2014DN09348A (pt) | ||
| PH12014501514A1 (en) | New azetidine derivatives, pharmaceutical compositions and uses thereof | |
| CR20200286A (es) | DERIVADOS DE DIHIDRO-BENZO-OXAZINA Y DIHIDRO-PIRIDO-OXAZINA (Divisional 2014-0294) | |
| GB2511685A (en) | Muscarinic m1 receptor agonists | |
| IN2012DN03182A (pt) | ||
| MX2012013274A (es) | Novedosos derivados de la pirimidina. | |
| EA201300250A1 (ru) | Оксадиазольные ингибиторы продуцирования лейкотриена | |
| MY169485A (en) | Heterocyclic compounds suitable for the treatment of dyslipidemia | |
| IN2014MN00697A (pt) | ||
| PH12014501195A1 (en) | Novel 2h-indazoles as ep2, receptor antagonists | |
| PH12017500595B1 (en) | Aldosterone synthase inhibitors | |
| PH12017500089B1 (en) | Aldosterone synthase inhibitors | |
| IN2013DN02555A (pt) | ||
| PH12014501943A1 (en) | Novel compounds for the treatment of dyslipidemia and related diseases | |
| IN2014KN01113A (pt) | ||
| MX2013006670A (es) | Derivado de 2-carboxamida-4-piperazinil-benzofurano. | |
| TN2013000122A1 (en) | Oxadiazole inhibitors of leukotriene production |